Literature DB >> 25589720

Neuroprotective effects of hydrated fullerene C60: cortical and hippocampal EEG interplay in an amyloid-infused rat model of Alzheimer's disease.

Vasily Vorobyov1, Vladimir Kaptsov1, Rita Gordon1, Ekaterina Makarova2, Igor Podolski2, Frank Sengpiel3.   

Abstract

We studied the effects of fullerene C60 nanoparticles, namely hydrated fullerene C60 (C60HyFn), on interrelations between EEG frequency spectra from the frontal cortex and the dorsal hippocampus (CA1) on an amyloid-β (Aβ) rat model of Alzheimer's disease (AD). Infusion of Aβ1-42 protein (1.5 μl) into the CA1 region two weeks before EEG testing diminished hippocampal theta (3.8-8.4 Hz) predominance and eliminated cortical beta (12.9-26.2 Hz) predominance observed in baseline EEG of rats infused with saline (control) or with C60HyFn alone. In contrast, these Aβ1-42 effects were abolished in rats pretreated with C60HyFn, 30 min apart. Dopaminergic mediation in AD has been shown to be involved in neuronal plasticity and Aβ transformation in different ways. To clarify its role in the cortex-hippocampus interplay in the Aβ model of AD, we used peripheral injection of a dopamine agonist, apomorphine (APO), at a low dose (0.1 mg/kg). In rats infused with C60HyFn or Aβ1-42 alone, APO attenuated the cortical beta predominance, with immediate and delayed phases evident in the Aβ1-42-rats. Pretreatment with C60HyFn diminished the APO effect in the Aβ1-42-treated rats. Thus, we show that intrahippocampal injection of Aβ1-42 dramatically disrupts cortical versus hippocampal EEG interrelations and that pretreatment with the fullerene eliminates this abnormality. We suggest that some effects of C60HyFn may be mediated through presynaptic dopamine receptors and that water-soluble C60 fullerenes have a neuroprotective potential.

Entities:  

Keywords:  Amyloid-β; brain oscillation; dopamine agonist; neurodegenerative disorder; neuroprotection

Mesh:

Substances:

Year:  2015        PMID: 25589720     DOI: 10.3233/JAD-142469

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice.

Authors:  Yawen Wu; Runzi Wang; Yuexiang Wang; Jing Gao; Lina Feng; Zhuo Yang
Journal:  Neurotox Res       Date:  2019-06-20       Impact factor: 3.911

2.  Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease.

Authors:  Hari Shanker Sharma; Dafin Fior Muresanu; José Vicente Lafuente; Ranjana Patnaik; Z Ryan Tian; Asya Ozkizilcik; Rudy J Castellani; Herbert Mössler; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

3.  Intracerebral interplay and neurotransmitter systems involvement in animal models of neurodegenerative disorders: EEG approach expectations.

Authors:  Vasily Vorobyov; Natalia Bobkova
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

4.  Novel C60 Fullerenol-Gentamicin Conjugate-Physicochemical Characterization and Evaluation of Antibacterial and Cytotoxic Properties.

Authors:  Aleksandra Nurzynska; Piotr Piotrowski; Katarzyna Klimek; Julia Król; Andrzej Kaim; Grazyna Ginalska
Journal:  Molecules       Date:  2022-07-07       Impact factor: 4.927

Review 5.  Carbon Nanomaterials Interfacing with Neurons: An In vivo Perspective.

Authors:  Michele Baldrighi; Massimo Trusel; Raffaella Tonini; Silvia Giordani
Journal:  Front Neurosci       Date:  2016-06-09       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.